{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:28:18Z","timestamp":1773829698557,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hematogenous disseminated tuberculosis predisposes to concurrent tuberculous meningitis (TBM), the most devastating and disabling form of tuberculosis. However, children often have atypical clinical symptoms, difficulty in specimen collection, low specimen content, and an increasing incidence of drug-resistant tuberculosis. Thus, the accurate diagnosis and timely treatment of childhood tuberculosis face monumental challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>The 14-year-old female presented to the hospital with intermittent fever, headache, and blurred vision.\u00a0Her cerebrospinal fluid (CSF) showed\u00a0a lymphocytic pleocytosis, an elevated protein level, and a decreased chloride level. And her CSF tested positive for TB-RNA. Xpert MTB\/RIF detected Mycobacterium tuberculosis in her CSF, but the rifampin resistance test was unknown.\u00a0Subsequently, her CSF culture was positive for Mycobacterium tuberculosis. The drug sensitivity test\u00a0(DST)\u00a0revealed\u00a0resistance to isoniazid, rifampin, and fluoroquinolones. A computed tomography (CT) of the chest showed\u00a0diffuse miliary nodules in both lungs. Intracranial enhanced magnetic resonance imaging (MRI) showed\u00a0\u201cmultiple intensified images of the brain parenchyma, cisterns, and part of the meninges.\u201d The final diagnosis is miliary pulmonary tuberculosis and pre-extensive drug-resistant\u00a0TBM.\u00a0After 19\u00a0months of an oral, individualized antituberculosis treatment, she recovered with no significant neurological sequelae.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>For patients with miliary pulmonary tuberculosis, especially children, even if there are no typical clinical symptoms, it is necessary to know whether there is TBM and other conditions. Always look for the relevant aetiological basis to clarify whether it is drug-resistant tuberculosis. Only a rapid and accurate diagnosis and timely and effective treatment can improve the prognosis and reduce mortality and disability rates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-07990-x","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T08:04:35Z","timestamp":1675757075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A case report about a child with drug-resistant tuberculous meningitis"],"prefix":"10.1186","volume":"23","author":[{"given":"Jing","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengqiu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"7990_CR1","unstructured":"World Health Organization\u20142022\u2014Global tuberculosis report 2022. pdf. (n.d.)."},{"issue":"4","key":"7990_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/microorganisms9040857","volume":"9","author":"R Basu Roy","year":"2021","unstructured":"Basu Roy R, Bakeera-Kitaka S, Chabala C, Gibb DM, Huynh J, Mujuru H, Sankhyan N, Seddon JA, Sharma S, Singh V, Wobudeya E, Anderson ST. Defeating Paediatric Tuberculous Meningitis: Applying the WHO \u201cDefeating Meningitis by 2030: Global Roadmap.\u201d Microorganisms. 2021;9(4):857. https:\/\/doi.org\/10.3390\/microorganisms9040857.","journal-title":"Microorganisms"},{"issue":"1","key":"7990_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00062-018-0726-9","volume":"29","author":"MA Schaller","year":"2019","unstructured":"Schaller MA, Wicke F, Foerch C, Weidauer S. Central nervous system tuberculosis: etiology, clinical manifestations and neuroradiological features. Clin Neuroradiol. 2019;29(1):3\u201318. https:\/\/doi.org\/10.1007\/s00062-018-0726-9.","journal-title":"Clin Neuroradiol"},{"key":"7990_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/20469047.2021.1952818","author":"HS Schaaf","year":"2021","unstructured":"Schaaf HS, Seddon JA. Management of tuberculous meningitis in children. Paediatr Int Child Health. 2021. https:\/\/doi.org\/10.1080\/20469047.2021.1952818.","journal-title":"Paediatr Int Child Health"},{"key":"7990_CR5","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TNMI7-0044-2017","author":"JM Leonard","year":"2017","unstructured":"Leonard JM. Central Nervous System Tuberculosis. Microbiol Spectrum. 2017. https:\/\/doi.org\/10.1128\/microbiolspec.TNMI7-0044-2017.","journal-title":"Microbiol Spectrum"},{"issue":"10202","key":"7990_CR6","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(19)31882-3","volume":"394","author":"C Lange","year":"2019","unstructured":"Lange C, Dheda K, Chesov D, Mandalakas AM, Udwadia Z, Horsburgh CR. Management of drug-resistant tuberculosis. Lancet. 2019;394(10202):953\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(19)31882-3.","journal-title":"Lancet"},{"issue":"1","key":"7990_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/pathogens11010038","volume":"11","author":"J Huynh","year":"2021","unstructured":"Huynh J, Abo Y-N, du Preez K, Solomons R, Dooley KE, Seddon JA. Tuberculous meningitis in children: reducing the burden of death and disability. Pathogens. 2021;11(1):38. https:\/\/doi.org\/10.3390\/pathogens11010038.","journal-title":"Pathogens"},{"key":"7990_CR8","unstructured":"World Health Organization. 2020. WHO consolidated guidelines on tuberculosis modul.pdf."},{"issue":"11","key":"7990_CR9","doi-asserted-by":"publisher","first-page":"e0241974","DOI":"10.1371\/journal.pone.0241974","volume":"15","author":"S Dian","year":"2020","unstructured":"Dian S, Hermawan R, van Laarhoven A, Immaculata S, Achmad TH, Ruslami R, Anwary F, Soetikno RD, Ganiem AR, van Crevel R. Brain MRI findings in relation to clinical characteristics and outcome of tuberculous meningitis. PLoS ONE. 2020;15(11):e0241974. https:\/\/doi.org\/10.1371\/journal.pone.0241974.","journal-title":"PLoS ONE"},{"key":"7990_CR10","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: Module 4: Treatment: Drug-susceptible tuberculosis treatment. World Health Organization. 2022. https:\/\/apps.who.int\/iris\/handle\/10665\/353829"},{"issue":"7","key":"7990_CR11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/resp.13304","volume":"23","author":"C Lange","year":"2018","unstructured":"Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda K. Drug-resistant tuberculosis: An update on disease burden, diagnosis, and treatment. Respirology. 2018;23(7):656\u201373. https:\/\/doi.org\/10.1111\/resp.13304.","journal-title":"Respirology"},{"issue":"10","key":"7990_CR12","doi-asserted-by":"publisher","first-page":"e00913","DOI":"10.1128\/AAC.00913-19","volume":"63","author":"EW Tucker","year":"2019","unstructured":"Tucker EW, Pieterse L, Zimmerman MD, Udwadia ZF, Peloquin CA, Gler MT, Ganatra S, Tornheim JA, Chawla P, Caoili JC, Ritchie B, Jain SK, Dartois V, Dooley KE. Delamanid central nervous system pharmacokinetics in tuberculous meningitis in rabbits and humans. Antimicrob Agents Chemother. 2019;63(10):e00913-e919. https:\/\/doi.org\/10.1128\/AAC.00913-19.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"7990_CR13","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.cmi.2019.03.021","volume":"25","author":"O Opota","year":"2019","unstructured":"Opota O, Mazza-Stalder J, Greub G, Jaton K. The rapid molecular test Xpert MTB\/RIF ultra: Towards improved tuberculosis diagnosis and rifampicin resistance detection. Clin Microbiol Infect. 2019;25(11):1370\u20136. https:\/\/doi.org\/10.1016\/j.cmi.2019.03.021.","journal-title":"Clin Microbiol Infect"},{"key":"7990_CR14","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: Module 5: management of tuberculosis in children and adolescents. World Health Organization. 2022. https:\/\/apps.who.int\/iris\/handle\/10665\/352522"},{"issue":"11","key":"7990_CR15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/14787210.2018.1540930","volume":"16","author":"RK Garg","year":"2018","unstructured":"Garg RK, Rizvi I, Malhotra HS, Uniyal R, Kumar N. Management of complex tuberculosis cases: a focus on drug-resistant tuberculous meningitis. Expert Rev Anti Infect Ther. 2018;16(11):813\u201331. https:\/\/doi.org\/10.1080\/14787210.2018.1540930.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"7990_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/INF.0000000000001464","volume":"36","author":"R Basu Roy","year":"2017","unstructured":"Basu Roy R, Seddon JA. Linezolid for children with tuberculous meningitis: more evidence required. Pediatric Infect Dis J. 2017;36(4):439. https:\/\/doi.org\/10.1097\/INF.0000000000001464.","journal-title":"Pediatric Infect Dis J"},{"key":"7990_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ921","author":"OW Akkerman","year":"2015","unstructured":"Akkerman OW, Odish OFF, Bolhuis MS, de Lange WCM, Kremer HPH, Luijckx G-JR, van der Werf TS, Alffenaar J-W. Pharmacokinetics of Bedaquiline in cerebrospinal fluid and serum in multidrug-resistant tuberculous meningitis. Clin Infect Dis. 2015. https:\/\/doi.org\/10.1093\/cid\/civ921.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-07990-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-07990-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-07990-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T08:05:02Z","timestamp":1675757102000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-07990-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7990"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-07990-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2261916\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,7]]},"assertion":[{"value":"11 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Ethics Review Boards, and with the informed consent of the patient\u2019s guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the parents of the patient for The publication of this Case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}